SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-048675
Filing Date
2024-04-26
Accepted
2024-04-26 08:36:11
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS 2024_prosy_ars.pdf ARS 12245604
  Complete submission text file 0000950170-24-048675.txt   16866847
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41551 | Film No.: 24879029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)